Literature DB >> 17869478

IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2.

Wendy Kleibeuker1, Eran Gabay, Annemieke Kavelaars, Jitske Zijlstra, Gilly Wolf, Nadav Ziv, Raz Yirmiya, Yehuda Shavit, Michael Tal, Cobi J Heijnen.   

Abstract

Many neurotransmitters involved in pain perception transmit signals via G protein-coupled receptors (GPCRs). GPCR kinase 2 (GRK2) regulates agonist-induced desensitization and signaling of multiple GPCRs and interacts with downstream molecules with consequences for signaling. In general, low GRK2 levels are associated with increased responses to agonist stimulation of GPCRs. Recently, we reported that in mice with reduced GRK2 levels, inflammation-induced mechanical allodynia was increased. In addition, mice with impaired interleukin (IL)-1 beta signaling did not develop mechanical allodynia after L5 spinal nerve transection (SNT). We hypothesized that in the L5 SNT model mechanical allodynia would be associated with reduced neuronal GRK2 levels in the spinal cord dorsal horn and that IL-1 beta signaling would be required to induce both the decrease in GRK2 and mechanical allodynia. We show here that in wild type (WT) mice L5 SNT induces a bilateral decrease in neuronal GRK2 expression in the lumbar spinal cord dorsal horn, 1 and 2 weeks after L5 SNT. No changes in GRK2 were observed in the thoracic segments. Moreover, spinal cord GRK2 expression was not decreased in IL-1R(-/-) mice after L5 SNT. These data show that IL-1 beta signaling is not only required for the development of mechanical allodynia, but also to reduce neuronal GRK2 expression. These results suggest a functional relation between the L5 SNT-induced IL-1 beta-mediated decrease in GRK2 and development of mechanical allodynia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869478     DOI: 10.1016/j.bbi.2007.07.009

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  28 in total

Review 1.  GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Authors:  Tama Evron; Tanya L Daigle; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2012-01-23       Impact factor: 14.819

Review 2.  Neuroinflammation and comorbidity of pain and depression.

Authors:  A K Walker; A Kavelaars; C J Heijnen; R Dantzer
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

Review 3.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.

Authors:  Linda R Watkins; Mark R Hutchinson; Kenner C Rice; Steven F Maier
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

Review 4.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

5.  Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

6.  GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain.

Authors:  Niels Eijkelkamp; Cobi J Heijnen; Hanneke L D M Willemen; Ronald Deumens; Elbert A J Joosten; Wendy Kleibeuker; Ilona J M den Hartog; Cindy T J van Velthoven; Cora Nijboer; Mohammed A Nassar; Gerald W Dorn; John N Wood; Annemieke Kavelaars
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

7.  Endogenous interleukin-1β in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-D-aspartic acid receptors.

Authors:  Xisheng Yan; Han-Rong Weng
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

Review 8.  [Pain in rheumatic diseases : What can biologics and JAK inhibitors offer?]

Authors:  G Pongratz
Journal:  Z Rheumatol       Date:  2021-01-14       Impact factor: 1.372

9.  p38 mediates mechanical allodynia in a mouse model of type 2 diabetes.

Authors:  Hsinlin T Cheng; Jacqueline R Dauch; Sang Su Oh; John M Hayes; Yu Hong; Eva L Feldman
Journal:  Mol Pain       Date:  2010-05-19       Impact factor: 3.395

Review 10.  Pathological pain and the neuroimmune interface.

Authors:  Peter M Grace; Mark R Hutchinson; Steven F Maier; Linda R Watkins
Journal:  Nat Rev Immunol       Date:  2014-02-28       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.